Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to regulation 30 of SEBI (LODR), please find the enclosed notices given to shareholders in accordance with applicable provision of SEBI listing regulation and the companies Act 2013 read with rules made thereunder, inter alia, informing them about 39th annual general meeting of the company and details relating to e-voting facility. Concord Biotech Ltd - 543960 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.- Intimation About EUGMP Certificate Issued By Health Product Regulatory Authority Of Ireland For Valthera Facility (Unit II) Of The Company
Intimation about EUGMP Certificate issued by Health Product Regulatory Authority of Ireland for Valthera Facility (Unit II) of the Company. Kindly take the above information on record. Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst/ Institutional Investor Meetings under SEBI (LODR) regulation, 2015 Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcripts of Q4 & FY24 Earning call Held on May 28, 2024 Concord Biotech Ltd - 543960 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for 1575773 Ontario INC
Concord Biotech Shareholder Pares Stake For Rs 482 Crore
Ontario Inc. owned 5.39% in the Jhunjhunwala family-backed company as of March 2024. Concord Biotech Ltd - 543960 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to the regulation 24A of the SEBI (LODR) Regulation (Amendment), 2018, Please find the enclosed annual secretarial compliance report for the year ended March 31, 2024. Kindly take the above on records. Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, and further to our intimation dated May 21, 2024 to the Stock exchanges regarding Earning call in respect of the audited (Standalone and Consolidated) Financial Results of the company for the fourth Quarter and year ended March 31, 2024, we wish to inform that the said Earning Call was held today at 04:00 PM (IST). The audio recording of the conference call has been hosted on the website of the company and link to access the said recording is as follows: - Link :- https://www.concordbiotech.com/public/assets/pdf/Q4FY24-earning-call-audio.mp3 Kindly take the above on records. Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to regulation 30 of schedule III Part A (LODR) regulation 2015, Investor Presentation on financial results for the fourth quarter and year ended March 31, 2024 is enclosed. Kindly take the above on records. Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to regulation of the SEBI (LODR) regulation, 2015, Please find the enclosed herewith the extracts of standalone and consolidated audited financial results for fourth quarter and year ended March 31, 2024 as published in Various Newspaper on May 24, 2024. Kindly take the above on records.